Skip to main content
Clinical Trials/NCT02325752
NCT02325752CompletedNot Applicable

A Prospective Randomised Control Trial to Study the Effectiveness of a Health Service Innovation Using a Modified Virtual Ward Model to Prevent Unscheduled Readmission of High Risk Patients

Singapore General Hospital0 sites840 target enrollmentStarted: August 1, 2011Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
840
Primary Endpoint
Rate of readmission

Study Overview

Brief Summary

The investigators conducted an open randomized control study of patients who received the transitional care program versus patients who received usual care at the Singapore General Hospital from Aug 2011 to Sept 2012.

Detailed Description

The investigators conducted an open randomized control study of patients who received the transitional care program versus patients who received usual care at the Singapore General Hospital from Aug 2011 to Sept 2012.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Health Services Research
Masking
Single (Participant)

Eligibility Criteria

Ages
21 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Patients with 2 or more unscheduled admission in the last 90 days to selected medical departments
  • •LACE score of ≥10.

Exclusion Criteria

  • •Non-residents
  • •No telephone contact or a resident address
  • •Residing in long term care facilities.

Arms & Interventions

Control

No Intervention

Patients in the control group received usual care by the hospital. There was no contact between the patients in the control group and the study team throughout the 3 months interval. A scheduled telephone call was made at the end of 3 months when they were invited to participate in a telephone survey.

Intervention

Active Comparator

Intervention

Intervention: Intervention (Other)

Outcomes

Primary Outcomes

Rate of readmission

Time Frame: 30 days

Any hospital admission after randomisation

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Similar Trials